Tag: drug shortages
-
Funding Priorities in Vaccines for Filoviruses, Pneumococcal Disease, and HIV Amid Drug Shortages in U.S. Health Care
Overview: Where Funding Goes for High-Stakes Vaccines As the U.S. health care system continually grapples with infectious disease threats, researchers and policymakers are placing renewed emphasis on vaccines that target filoviruses, pneumococcal disease, and HIV. These three areas represent different but equally consequential fronts in public health: filoviruses like Ebola and Marburg can cause severe…
-
Vaccines Funds for Filoviruses, Pneumococcal Disease, HIV
New financing aims to accelerate vaccines for major threats Researchers and policymakers are rallying around new funding initiatives designed to fast‑track vaccines targeting filoviruses, pneumococcal disease, and HIV. The push comes amid growing recognition that diversified vaccine programs can reduce disease burden, save lives, and stabilize health systems facing unpredictable outbreaks and rising antimicrobial resistance.…
-
Quick Takes: Funding for Vaccines Targeting Filoviruses, Pneumococcal Disease, and HIV, and the Drug Shortage Dilemma
Funding Momentum for Key Vaccines As global health priorities shift toward preventing severe infections, researchers and policymakers are mobilizing resources to accelerate vaccines targeting filoviruses, pneumococcal disease, and HIV. These three areas represent distinct challenges: filoviruses (which include Ebola and related viruses) demand rapid-response vaccines for outbreak control; pneumococcal disease requires broad protection across serotypes…
-
Canada’s Pain Medication Shortages Hit Chronic Pain Patients
Canada’s Pain Medication Shortages: An Everyday Crisis Across the country, chronic pain patients are navigating a growing and frustrating barrier to relief: a nationwide shortage of a commonly used combination medication—acetaminophen with oxycodone. For people who rely on this drug to manage severe pain and maintain a semblance of daily life, the shortage looks less…
-
Canada’s Pain Medication Shortages Leave Chronic Pain Patients in Limbo
Chronic Pain in Canada Meets a Mysterious Shortage Across Canada, chronic pain patients are confronting a troubling reality: shortages in commonly prescribed pain medications have disrupted treatment plans, daily routines, and quality of life. From acetaminophen with oxycodone to other staple analgesics, patients report delays, substitutions, and escalating anxiety about future access. The human stories…
-
European Study Highlights Falling Prices, Higher Costs, and Shortages in AMR Treatments
Overview: What the European study found During World AMR Awareness Week, an independent European study presented by Viatris and Medicines for Europe sheds light on a complex trend impacting antimicrobial resistance (AMR) treatment: prices are falling, costs are rising, and shortages are increasingly common. The report synthesizes data from multiple European markets, comparing recent price…
-
India-Botswana Pharma MoU expands medicine access worldwide
Strengthening Medicine Access Through Partnership During President Droupadi Murmu’s state visit, India and Botswana formalized a landmark pharmaceutical cooperation agreement aimed at expanding access to medicines and addressing persistent drug shortages in Botswana. The memorandum of understanding (MoU) signals a strategic shift in health diplomacy, leveraging India’s robust pharmaceutical sector to support Botswana’s health emergency…
-
India-Botswana Sign MoU to Expand Access to Medicines Amid Health Emergency
India and Botswana Sign MoU to Expand Access to Medicines The governments of India and Botswana have formalized their commitment to improving public health by signing a memorandum of understanding (MoU) focused on expanding access to medicines. The accord was announced during the state visit of the President of India, in a move that underscores…